Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Deborah Dunsire
Age : 58
Public asset : 1,313,729 USD
Country of residence : Unknown
Linked companies : H. Lundbeck A/S - Ultragenyx Pharmaceutical Inc.

Biography of Deborah Dunsire 
Currently, Deborah L. Dunsire is President & Chief Executive Officer for H. Lundbeck A. She is also Secretary at Biotechnology Innovation Organization and on the board of 6 other companies. In her past career Dr. Dunsire held the position of President, Chief Executive Officer & Director at FORUM Pharmaceuticals, Inc., President, Chief Executive Officer & Director at XTuit Pharmaceuticals, Inc., Vice President-Oncology Business Unit at Novartis AG and Senior Vice President-North America Oncology at Novartis Oncology, Inc. (a subsidiary of Novartis AG) and Director at Takeda Pharmaceutical Co., Ltd. and President, Chief Executive Officer & Director at Millennium Pharmaceuticals, Inc. (a subsidiary of Takeda Pharmaceutical Co., Ltd.). Dr. Dunsire received a graduate degree from the University of the Witwatersrand.


Current positions of Deborah Dunsire 
Holdings of Deborah Dunsire 
Deborah Dunsire : Personal Network 
Most Read News 
09/04BERNARD ARNAULT : There is no conflict with Arnault
RE
09/07GEORGE SOROS : Soros says BlackRock's China investments likely to lose money - WSJ
RE
09/14BRAD SMITH : Microsoft to buy back up to $60 billion in shares; names Brad Smith vice chair
RE
09/09FRANCESCO GAETANO CALTAGIRONE : Italy's Caltagirone ups Generali stake to just over 6%
RE
09/14CATHIE WOOD : ARK Invest's Wood expects market rotation back to growth stocks
RE
09/09ELON MUSK : Tesla's Musk asks staff to 'go super hardcore' to ensure decent Q3 delivery number
RE
09/13MARTIN SORRELL : Sorrell's S4 Capital raises annual profit outlook for a third time
RE
09/08ELON MUSK : Amazon.com goes for jugular in FCC spat with SpaceX's Musk
RE
09/08BILL GATES : Bill Gates' investment firm to take control of Four Seasons in $2.21 billion deal
RE
09/17STELIOS HAJI-IOANNOU : EasyJet shareholder Stelios Haji-Ioannou shuns rights issue -source
RE
More news


© 2021 People and Ownership :   
Deborah Dunsire : Connections 


Latest news about Deborah Dunsire 
09/10Syros Pharmaceuticals, Inc. Appoints Deborah Dunsire as A Class II Director
CI
08/18H LUNDBECK A/S : Drugmaker Lundbeck lowers sales outlook as generic competition bites
RE
2020Activist investor Elliott pushes Alexion Pharma to sell itself
RE
2020Activist investor Elliott pushes Alexion Pharma to sell itself
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
2020Lundbeck boosted by stockpiling, launches key drug remotely
RE
More news